NMXS — Net Medical Xpress Solutions Share Price
Last trade - 00:00- $0.22m
- $0.06m
- $3.05m
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | n/a | ||
| PEG Ratio (f) | n/a | ||
| EPS Growth (f) | n/a | ||
| Dividend Yield (f) | n/a | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | 1.11 | ||
| Price to Tang. Book | 6.02 | ||
| Price to Free Cashflow | n/a | ||
| Price to Sales | 0.08 | ||
| EV to EBITDA | n/a | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | -146.5% | ||
| Return on Equity | -91.27% | ||
| Operating Margin | -10.96% | ||
Financial Summary
| Year End 31st Dec | Unit | 2012 | 2013 | 2014 | 2015 | 2016 | 2017E | 2018E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | $m | 3.9 | 4.81 | 4.58 | 4.22 | 3.04 | n/a | n/a | -1.03% |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | n/a | +446.67 | n/a | n/a | n/a | n/a | n/a | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
Net Medical Xpress Solutions, Inc. focuses on the development of artificial intelligence software named PrivateAI (Private Eye), developing clinical trials, and expanding immune defense products to different markets. The Company is also focusing on productizing hand-labeled image data for use in artificial intelligence training, verification, and validation of custom models. It focuses on artificial intelligence for medical research, clinical trials, and Food and Drug Administration (FDA) compliance, which includes cybersecurity audit products designed to meet the FDA's new mandates for connected devices. Through its subsidiary, Immunity Science, Inc., the Company provides a variety of over-the-counter vitamins, supplements, air purifiers, nasal sprays, and drug-free pain patches. It offers its products through the Website www.immunityscience.store direct to consumers. In addition, products are available from distribution centers at retail locations.
Directors
- Last Annual
- December 31st, 2016
- Last Interim
- September 30th, 2017
- Incorporated
- December 23rd, 2005
- Public Since
- November 22nd, 2000
- No. of Employees
- 19
- Sector
- Software & IT Services
- Industry
- Technology
- Exchange
- Pink Sheets on Nasdaq
- Shares in Issue
- 37,667,581
- Address
- 8206 Louisiana Blvd., Suite A, ALBUQUERQUE, 87113
- Web
- https://www.welcome.netmedical.com/
- Phone
- +1 5052551999
- Auditors
- RBSM LLP
Upcoming Events for NMXS
Similar to NMXS
1606
Pink Sheets on Nasdaq
Ablaze Technologies
Pink Sheets on Nasdaq
Accelerated Technologies Holding
Pink Sheets on Nasdaq
Acorn Energy
Pink Sheets on Nasdaq
Advantego
Pink Sheets on Nasdaq
FAQ
As of Today at 10:14 UTC, shares in Net Medical Xpress Solutions are trading at $0.01. This share price information is delayed by 15 minutes.
Shares in Net Medical Xpress Solutions last closed at $0.01 and the price had moved by -42.5% over the past 365 days. In terms of relative price strength the Net Medical Xpress Solutions share price has underperformed the S&P500 Index by -46.68% over the past year.
There is no consensus recommendation for this security.
Find out moreNet Medical Xpress Solutions does not currently pay a dividend.
Net Medical Xpress Solutions does not currently pay a dividend.
Net Medical Xpress Solutions does not currently pay a dividend.
To buy shares in Net Medical Xpress Solutions you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
As of the previous close price of $0.01, shares in Net Medical Xpress Solutions had a market capitalisation of $0.22m.
Here are the trading details for Net Medical Xpress Solutions:
- Country of listing: United States
- Exchange: PNK
- Ticker Symbol: NMXS
Based on an overall assessment of its quality, value and momentum Net Medical Xpress Solutions is currently classified as a . The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
We could not find analyst target price data for this security.
Find out moreAn important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Net Medical Xpress Solutions. Over the past six months, its share price has underperformed the S&P500 Index by -53.51%.
As of the last closing price of $0.01, shares in Net Medical Xpress Solutions were trading -88.99% below their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
The Net Medical Xpress Solutions PE ratio based on its reported earnings over the past 12 months is null. The shares last closed at $0.01.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Net Medical Xpress Solutions' management team is headed by:
- Richard Govatski - CHM
- Teresa Dickey - SEC
- John Handley - IND
- Frank Reidy - IND